Results 1 to 10 of about 25,820 (298)
Chronic Hyperphosphatemia and Vascular Calcification Are Reduced by Stable Delivery of Soluble Klotho. [PDF]
Journal of the American Society of Nephrology, 2017 αKlotho (αKL) regulates mineral metabolism, and diseases associated with αKL deficiency are characterized by hyperphosphatemia and vascular calcification (VC).
J. Hum +10 more
semanticscholar +4 more sources
Saudi Medical Journal, 2015 Hyperphosphatemia is a major cause of morbidity and mortality in patients with chronic kidney disease. The association between hyperphosphatemia and increased risk of death from cardiovascular disease/vascular calcification has been well established for a long time.
A. Askar
semanticscholar +4 more sources
Hyperphosphatemia and Cardiovascular Disease [PDF]
Frontiers in Cell and Developmental Biology, 2021 Hyperphosphatemia or even serum phosphate levels within the “normal laboratory range” are highly associated with increased cardiovascular disease risk and mortality in the general population and patients suffering from chronic kidney disease (CKD). As the kidney function declines, serum phosphate levels rise and subsequently induce the development of ...
Chao Zhou +4 more
openaire +5 more sources
Hyperphosphatemia and Outcomes in Critically Ill Patients: A Systematic Review and Meta-Analysis
Frontiers in Medicine, 2022 IntroductionSerum phosphate level is often deranged during critical illness. Hyperphosphatemia, as a marker of disease severity, attracts more and more attention.
Wen-He Zheng +4 more
doaj +2 more sources
Journal of Veterinary Internal Medicine, 2021 Background Fibroblast growth factor (FGF)‐23 is increased first in the sequence of changes associated with chronic kidney disease (CKD)‐mineral and bone disorder.
Hirosumi Miyakawa +5 more
doaj +2 more sources
Hyperphosphatemia is associated with high mortality in severe burns. [PDF]
PLoS ONE, 2018 Phosphate level is often deranged during acute illness, regardless of the presence of kidney injury or not. A few studies described that hypophosphatemia may associated with outcome in patients admitted to the burn unit, but the literatures for ...
George Kuo +10 more
doaj +2 more sources
Dietary Therapy for Managing Hyperphosphatemia [PDF]
Clinical Journal of the American Society of Nephrology, 2020 Hyperphosphatemia is a prevalent complication in patients with advanced CKD, affecting approximately 50% of those treated with maintenance hemodialysis ([1][1],[2][2]). In the normal state, phosphate homeostasis is maintained through the interplay between intestinal absorption, bone deposition ...
Yoko Narasaki, Connie M. Rhee
openaire +4 more sources
Effect of Intradialytic Exercise on Hyperphosphatemia and Malnutrition [PDF]
Nutrients, 2019 Intradialytic exercise (IDE) is not routinely prescribed in hemodialysis (HD) units despite its potential benefits on patients’ outcomes. This study was the first in the United Arab Emirates to examine the effect of aerobic IDE on hyperphosphatemia, malnutrition, and other health outcomes among HD patients.
Nada Salhab +6 more
openaire +5 more sources
Efficacy and safety of tenapanor in end-stage renal disease patients with hyperphosphatemia: a systematic review and meta-analysis [PDF]
Renal FailureBackground Hyperphosphatemia occurs universally in end-stage renal disease(ESRD), and the attainment of target serum phosphate levels remains suboptimal with currently available phosphate binders.
Shanshen Yu, Jia Sun, Xiafei Guo
doaj +2 more sources
American Journal of Kidney Diseases, 2023 RATIONALE & OBJECTIVE Patients with chronic kidney disease (CKD), hyperkalemia (serum potassium [sK+] >5.0 mEq/L), and hyperphosphatemia experience poor clinical outcomes.
D. Bushinsky +5 more
semanticscholar +1 more source